61MO Perceptions of healthcare professionals and regulators on the use of real-world data as external comparators in late-stage oncology single-arm trials

Real-world data (RWD) have potential applications for complementing other data sources, including as external comparators for single-arm trials (SAT). We aimed to explore perceptions about this methodology in the setting of advanced cancer of high unmet medical need.